Herpes Simplex
Conditions
Brief summary
This study intends to test the efficacy of the TheraNeem Lip Therapy balm for Herpes Simplex. The study will include a total of 5 people.
Detailed description
Qualified candidates will be officially enrolled into the study within 24 hours of their subsequent outbreak of Herpes Simplex Labialis. They will be given all of the Neem Therapy products to use, and photographs and questionnaires will be taken to assess their progress.
Interventions
Apply externally 3-4 times per day
Sponsors
Study design
Eligibility
Inclusion criteria
1. Participant has signs and symptoms of HSV-1 infection of less than 24 hours duration to the Southern California University of Health Sciences investigators 2. Participants ages 18-70 years 3. Confirmation of oral-circumoral herpes lesion will be made by a clinician in the presence of oral-circumoral lesion assumed to be HSV-1 for purposes of study 4. Subjects expressed willingness to comply with protocol 5. Subject will be willing to have the presenting lesion photographed twice 6. Subject sign a written informed consent, HIPPA disclosure, Experimental bill of rights
Exclusion criteria
1. History of past or present immunosuppressive condition, or currently taking immunosuppressive medication 2. History of adverse effects or allergies to any Neem based product or containing any of the other ingredients TheraNeem Lip Therapy: Organic Coconut Oil, Organic Beeswax, Organic Jojoba Oil, Shea Butter, Sesame Oil, Organic Neem Oil, , Essential Oil of Peppermint, Vitamin E (Tocopherol) 3. Signs of disseminated HSV illness 4. History of use of oral or topical antiviral agents within 10 days of screening and/or at start of study visit 5. Pregnancy or lactation 6. Psychiatric disorder 7. Inability to understand or follow the instructions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cold Sore Symptom Scale | Baseline and End of Treatment |
Countries
United States